glp-1 and bowel obstruction Can Glucagon-like peptide-1 (GLP-1) receptor agonists cause intestinal obstruction? glp-1 bowel obstruction class action

Two people enrolling in the same program on the same day can end up paying different amounts because their prescribed compound, dose, and dispensing route differ

The observation that the insulinotropic actions of GLP-1 are reduced in type 2 diabetes mellitus (T2DM) led to the development of incretin-based therapies GLP-1 receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of hyperglycaemia in these patients

Weight loss typically plateaus after 12 to 18 months, but this reflects reaching a new metabolic equilibrium rather than medication failure

Understand how to attach the needle, prime the pen (if required for the first use), dial to your prescribed 0.25 mg starting dose, and select an injection site (typically the lower abdomen or thigh)

Do not exceed the max dose of 0.4mg per week

Missing a single dose during the dose schedule does not require restarting the titration